Preclinical studies have shown that elevated levels of PLIN2 are associated with several metabolic disorders, including obesity, diabetes, fatty liver disease, atherosclerosis and cardiovascular disease, and inhibiting PLIN2 has been shown to prevent or alleviate these conditions [18]. This evidence concerns the gene PLIN2 and metabolic disease.